Your session is about to expire
← Back to Search
SM-88 for Breast Cancer (OASIS Trial)
OASIS Trial Summary
This trial is testing a new combo treatment for metastatic breast cancer. They want to see if it's effective and has acceptable side effects.
- Metastatic Breast Cancer
- Breast Cancer
OASIS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOASIS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OASIS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the participant pool size for this clinical examination?
"Indeed, the clinicaltrials.gov website confirms that this medical investigation is actively seeking participants after being initially released on September 22nd 2021 and last updated on November 2nd 2022. The trial requires 50 patients from 5 different sites to contribute data."
Is SM-88 a safe drug to administer to individuals?
"There is some evidence of SM-88's safety, giving it an appraisal of 2 on the risk scale. However, there are no studies yet that confirm its efficacy in treating cancer."
Are there any unfilled roles in this medical experiment?
"Accurate. Clinicaltrials.gov reports that this clinical trial is actively seeking participants, having first been posted on September 22nd 2021 and lastly amended on November 2nd 2022."
Share this study with friends
Copy Link
Messenger